Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1975 2
1977 1
1978 2
1986 1
1987 2
1990 1
1992 2
1994 1
1995 2
1997 1
2014 1
2016 4
2017 2
2018 4
2019 3
2021 1
2022 2
2023 1
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).
Hartmann S, Banys-Paluchowski M, Berger T, Ditsch N, Stickeler E, de Boniface J, Gentilini OD, Schroth J, Karadeniz Cakmak G, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D, Kadayaprath G, Pinto D, Peintinger F, Schlichting E, Dostalek L, Nina H, Valiyeva H, Vanhoeij M, Perhavec A, Zippel D, Rebaza LP, Thongvitokomarn S, Fröhlich S, Ruf F, Rief A, Wihlfahrt K, Basali T, Thill M, Lux MP, Loibl S, Kolberg HC, Blohmer JU, Hahn M, Gurleyik MG, Porpiglia M, Gunay S, Zetterlund L, Kuehn T; AXSANA Study Group. Hartmann S, et al. Eur J Surg Oncol. 2025 Sep;51(9):110253. doi: 10.1016/j.ejso.2025.110253. Epub 2025 Jun 25. Eur J Surg Oncol. 2025. PMID: 40587927 Free article.
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers.
Ortmann O, Blohmer JU, Sibert NT, Brucker S, Janni W, Wöckel A, Scharl A, Dieng S, Ferencz J, Inwald EC, Wesselmann S, Kowalski C; for 55 breast cancer centers certified by the German Cancer Society. Ortmann O, et al. J Cancer Res Clin Oncol. 2023 Mar;149(3):1195-1209. doi: 10.1007/s00432-022-03938-x. Epub 2022 Apr 5. J Cancer Res Clin Oncol. 2023. PMID: 35380257 Free PMC article.
Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving Anthracycline-Cyclophosphamide-Based Chemotherapy.
Schilling J, Kurbacher CM, Hanusch C, Busch S, Holländer M, Kreiss-Sender J, Rezek D, Flahaut E, Karthaus M. Schilling J, et al. Among authors: rezek d. Breast Care (Basel). 2022 Apr;17(2):130-136. doi: 10.1159/000514891. Epub 2021 May 25. Breast Care (Basel). 2022. PMID: 35702496 Free PMC article.
Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
Rhiem K, Bücker-Nott HJ, Hellmich M, Fischer H, Ataseven B, Dittmer-Grabowski C, Latos K, Pelzer V, Seifert M, Schmidt A, Rezek D, Groh U, Meinerz W, Crommelinck D, Hahnen E, Wesselmann S, Schmutzler RK. Rhiem K, et al. Among authors: rezek d. Breast J. 2019 May;25(3):455-460. doi: 10.1111/tbj.13257. Epub 2019 Apr 5. Breast J. 2019. PMID: 30953388
[Current Perceptions of Lipofilling on the Basis of the New Guideline on "Autologous Fat Grafting"].
Prantl L, Rennekampff HO, Giunta RE, Harder Y, von Heimburg D, Heine N, Herold C, Kneser U, Lampert F, Machens HG, Mirastschijski U, Müller D, Pallua N, Schantz T, Schönborn A, Ueberreiter K, Witzel CH, Bull G, Rezek D, Sattler G, Vogt PM, Horch RE. Prantl L, et al. Among authors: rezek d. Handchir Mikrochir Plast Chir. 2016 Dec;48(6):330-336. doi: 10.1055/s-0042-117635. Epub 2016 Nov 10. Handchir Mikrochir Plast Chir. 2016. PMID: 27832668 German.
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Hack CC, Fasching PA, Fehm T, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Brucker SY, Wallwiener D, Kümmel S, Beckmann MW, Paepke D. Hack CC, et al. Among authors: rezek d. Integr Cancer Ther. 2017 Jun;16(2):165-175. doi: 10.1177/1534735416668575. Epub 2016 Sep 14. Integr Cancer Ther. 2017. PMID: 27627986 Free PMC article.
34 results